Synovial cell sarcoma

Synovial cell sarcoma is a rare malignant tumor that arises from cells associated with joint structures in cats. Despite its name, which suggests origin from the synovial membrane lining joints, the true cellular origin of this tumor remains debated, and it may arise from primitive mesenchymal cells near joints rather than from differentiated synovial cells. The tumor typically develops in close association with joints, tendons, or bursae, most commonly affecting the limbs, particularly around the stifle, hock, and elbow joints. Synovial cell sarcoma is considerably less common than other soft tissue sarcomas in cats, but it represents an important diagnosis due to its aggressive local behavior and tendency to cause significant lameness and joint dysfunction. Middle-aged to older cats are most commonly affected, though the tumor can occur at any age.

The causes of synovial cell sarcoma in cats are not well understood, as is typical for most spontaneous feline cancers. The tumor develops when cells in or around joint structures undergo malignant transformation through accumulated genetic mutations. No specific environmental factors, infectious agents, or other triggers have been consistently associated with synovial cell sarcoma development in cats. The tumor's predilection for joint regions suggests that something about this microenvironment may predispose to tumor development, but the specific factors involved remain unknown. Trauma to joints has been proposed as a potential contributing factor in some cases, though this association has not been definitively established.

Synovial cell sarcoma significantly affects the quality of life of affected cats through progressive lameness, pain, and loss of normal joint function. The tumor's location adjacent to joints means that it frequently interferes with mobility even when relatively small. As the tumor grows, it can erode into the joint space, invade surrounding bone, and compress or damage nerves and blood vessels. Pain from the tumor and associated joint dysfunction leads to decreased activity, reluctance to jump or play, and overall reduction in quality of life. The local invasiveness of synovial cell sarcoma makes it challenging to treat, as complete surgical removal often requires extensive surgery or amputation of the affected limb.

Treatment of synovial cell sarcoma typically requires aggressive surgery, with amputation often providing the best chance for complete tumor removal and long-term control. The tumor's tendency to invade surrounding structures extensively makes achieving wide surgical margins challenging without amputation. For tumors where amputation is not feasible or desired, wide local excision combined with radiation therapy may provide an alternative approach, though local recurrence rates are generally higher than with amputation. Early detection and prompt treatment offer the best outcomes, making it essential for cat owners to seek veterinary evaluation of any persistent joint swelling, lameness, or masses near joints. Working with a veterinary oncologist ensures access to the full range of treatment options and expertise in managing this challenging tumor type.

The primary causes of synovial cell sarcoma in cats remain poorly understood, and most cases are considered to arise spontaneously without an identifiable trigger. At the cellular level, the tumor develops when cells in the periarticular region undergo malignant transformation through accumulated genetic mutations that disrupt normal growth regulation. The cellular origin of synovial cell sarcoma has been debated, with some evidence suggesting origin from synovial cells and other evidence supporting origin from primitive mesenchymal stem cells that happen to be located near joint structures. Regardless of the precise cell of origin, the result is a tumor with characteristic histological features and biological behavior.

Genetic factors in feline synovial cell sarcoma have not been well characterized due to the tumor's rarity. No breed predisposition has been identified, suggesting that if genetic susceptibility exists, it likely involves common genetic variants present across the cat population rather than breed-specific mutations. Studies in humans have identified specific chromosomal translocations associated with synovial sarcoma, but whether similar genetic alterations occur in feline tumors is not well established. The lack of clear hereditary patterns makes genetic counseling or breeding decisions irrelevant for this condition. Research into the genetics of feline synovial cell sarcoma is limited by the tumor's uncommon occurrence.

Environmental and lifestyle factors that might contribute to synovial cell sarcoma development in cats have not been identified. Joint trauma has been proposed as a potential contributing factor, as chronic tissue damage and repair could theoretically create conditions favorable for malignant transformation. Some authors have suggested associations with previous joint disease or chronic joint inflammation, though these connections remain speculative. No specific environmental exposures, infectious agents, or dietary factors have been linked to synovial cell sarcoma risk. Indoor versus outdoor lifestyle has not been shown to influence risk for this tumor type.

Risk factors for synovial cell sarcoma in cats are not well defined. Age appears to be a factor, with middle-aged to older cats more commonly affected than young cats, consistent with the general pattern of cancer risk increasing with age. Both male and female cats can develop synovial cell sarcoma, with no consistent sex predisposition reported in the literature. The joints most commonly affected include the stifle, hock, and elbow, though tumors can arise near any joint. Whether cats with pre-existing joint disease or previous joint injuries are at increased risk has not been definitively established.

The mechanism of synovial cell sarcoma development involves malignant transformation of cells in the periarticular region, leading to uncontrolled proliferation and local invasion. Normal cells in the joint region, whether synovial cells or mesenchymal progenitors, are subject to regulatory mechanisms that control their growth and prevent tumor formation. Genetic mutations that disable these regulatory mechanisms allow affected cells to proliferate without normal constraints. The resulting tumor grows progressively, invading adjacent structures including the joint capsule, surrounding soft tissues, and potentially the underlying bone. The aggressive local behavior of synovial cell sarcoma reflects its ability to extend far beyond the visible tumor margins through microscopic extensions into surrounding tissues.

The earliest warning signs of synovial cell sarcoma in cats typically involve subtle changes in mobility or behavior related to the affected joint. Owners may notice mild lameness that initially comes and goes or appears only after activity. There may be slight stiffness when the cat first gets up from rest, which improves with movement. Decreased interest in activities requiring use of the affected limb, such as jumping or climbing, may occur. Cats are adept at hiding discomfort, so early signs may be quite subtle and easily attributed to minor injury or aging. Careful observation and awareness that any persistent lameness warrants veterinary attention can help detect problems early when treatment is most effective.

Common symptoms of synovial cell sarcoma become more apparent as the tumor grows and increasingly affects the joint and surrounding structures. Progressive lameness is the hallmark symptom, typically worsening over weeks to months. Swelling around the affected joint may become visible or palpable, often described as firm and fixed rather than soft and moveable. The cat may show reluctance to bear weight on the affected limb or may carry the leg elevated. Range of motion in the affected joint may become limited as the tumor interferes with normal joint mechanics. Pain when the affected area is touched or manipulated is common as the tumor grows.

Behavioral changes in cats with synovial cell sarcoma reflect pain and functional limitations from the growing tumor. Decreased overall activity is common, with cats spending more time resting and less time playing or exploring. Changes in jumping behavior are often noted, with cats avoiding high surfaces they previously accessed easily or using alternative routes that require less jumping. Gait changes may include obvious limping, bunny-hopping with both hind legs, or reluctance to use stairs. Irritability when handled, particularly around the affected area, may develop as discomfort increases. Changes in appetite, grooming, and litter box habits may occur as the cat's general wellbeing declines.

Physical signs of synovial cell sarcoma include a mass or swelling associated with a joint, which is typically firm and may feel fixed to underlying structures. The overlying skin usually appears normal initially but may become stretched and taut as the tumor enlarges. Hair loss or skin changes over the mass may develop with advanced disease. Muscle wasting in the affected limb is common due to decreased use. The joint itself may feel thickened, and there may be reduced range of motion on manipulation. Warmth over the affected area may be present due to inflammation. Regional lymph nodes may be enlarged if the tumor has spread locally.

Symptom progression in synovial cell sarcoma follows a pattern of gradual worsening as the tumor grows and invades surrounding structures. What begins as mild, intermittent lameness typically becomes more constant and severe over time. The tumor may eventually erode into the joint space, causing more significant dysfunction and potentially joint instability. Bone invasion can cause pathological fractures in some cases. As the tumor enlarges, it may compress or damage nearby nerves, causing neurological deficits such as weakness, numbness, or altered sensation in the affected limb. Weight loss and general decline may occur in advanced stages.

Emergency symptoms requiring immediate veterinary attention may develop in certain situations. Sudden, severe worsening of lameness could indicate pathological fracture or other acute complications. Complete inability to bear weight on the affected limb warrants urgent evaluation. Signs of severe pain such as vocalization, extreme reluctance to move, or aggressive behavior when approached require prompt assessment. Any acute neurological changes, including sudden weakness or loss of function in the limb, should be evaluated emergently. Rapid increase in swelling size or development of open wounds on the tumor surface indicate concerning changes that need immediate attention.

The initial veterinary examination for suspected synovial cell sarcoma begins with a thorough history and comprehensive physical assessment. The veterinarian will ask detailed questions about the onset and progression of lameness, any changes in activity or behavior, and whether any previous injuries or joint problems have occurred. Physical examination includes careful palpation of the affected area, assessing the size, location, and characteristics of any masses, as well as their relationship to the underlying joint. Orthopedic examination evaluates range of motion, joint stability, and pain response. Neurological assessment checks for any deficits in the affected limb. Examination of regional lymph nodes assesses for potential spread, and a complete physical evaluation determines overall health status.

Diagnostic imaging is essential for characterizing synovial cell sarcoma and planning appropriate treatment. Radiographs of the affected limb reveal the relationship between the tumor and underlying bony structures, showing whether bone invasion has occurred. Characteristic radiographic findings may include soft tissue mass adjacent to a joint with possible bone lysis or periosteal reaction. Chest radiographs evaluate the lungs for metastatic disease, though metastasis at initial presentation is relatively uncommon. Advanced imaging with computed tomography provides detailed information about tumor extent and involvement of surrounding structures, which is crucial for surgical planning. CT imaging can detect subtle bone involvement and helps determine whether limb-sparing surgery might be feasible.

Tissue diagnosis is essential for confirming synovial cell sarcoma and distinguishing it from other tumors affecting the periarticular region. Fine needle aspiration may provide preliminary information but is often insufficient for definitive diagnosis of soft tissue sarcomas. Tissue biopsy, either incisional or excisional, provides material for histopathological examination. The pathologist evaluates tissue architecture and cell morphology to identify features characteristic of synovial cell sarcoma, which may include biphasic patterns with epithelial and spindle cell components, though monophasic variants occur. Immunohistochemistry using various antibody markers helps confirm the diagnosis and distinguish synovial cell sarcoma from other tumor types.

Differential diagnosis for periarticular masses includes several other tumor types and non-neoplastic conditions. Other soft tissue sarcomas including fibrosarcoma, peripheral nerve sheath tumor, and undifferentiated sarcoma can occur in similar locations. Histiocytic sarcoma may arise near joints and mimic synovial cell sarcoma on initial examination. Non-neoplastic conditions including joint infections, immune-mediated joint disease, and chronic inflammatory conditions can cause joint swelling and lameness. Bone tumors such as osteosarcoma arising in periarticular bone must also be considered. Accurate diagnosis through histopathological examination is essential because treatment approaches and expected outcomes differ significantly among these conditions.

Treatment of synovial cell sarcoma in cats requires aggressive intervention to achieve the best possible outcomes. Initial management focuses on pain control and patient stabilization while diagnostic workup is completed. Strong pain medications, often including opioids, provide relief from the significant discomfort associated with periarticular tumors. Once the diagnosis is confirmed and staging is complete, the treatment plan can be finalized. Referral to a veterinary oncologist or surgeon with experience in soft tissue sarcomas and periarticular tumors ensures access to current best practices and the full range of treatment options. The locally aggressive nature of synovial cell sarcoma makes complete excision challenging and influences treatment recommendations.

Surgical amputation is often the recommended treatment for synovial cell sarcoma affecting the limbs, as it provides the widest possible margins and eliminates the tumor-bearing limb entirely. The proximity of these tumors to joints, tendons, nerves, and blood vessels makes achieving adequate margins with limb-sparing surgery extremely challenging in most cases. Amputation eliminates concerns about incomplete excision and provides the best chance for local tumor control. Although the prospect of amputation may seem daunting to owners, cats adapt remarkably well to three-legged life. Most cats are walking comfortably within days to weeks of surgery and return to near-normal activity levels over time, including climbing, playing, and jumping.

Limb-sparing surgery may be considered in selected cases where the tumor location and extent make wide local excision potentially achievable. This approach aims to remove the tumor with adequate margins while preserving the limb. Success depends heavily on tumor size, location, and extent of involvement of critical structures. Limb-sparing surgery for synovial cell sarcoma carries higher risk of incomplete excision and local recurrence compared to amputation. When limb-sparing surgery is attempted, the excised tissue should be carefully evaluated by a pathologist to assess whether margins are complete. Incomplete margins significantly increase recurrence risk and may necessitate additional treatment or eventual amputation.

Radiation therapy plays an important role in managing synovial cell sarcoma, particularly as an adjunct to limb-sparing surgery. Preoperative radiation may shrink the tumor and improve surgical margins. Postoperative radiation targets any microscopic residual disease and is especially important when surgical margins are narrow or positive. Definitive radiation may be used as primary treatment when surgery is not feasible due to tumor location or patient factors. Radiation protocols typically involve multiple treatments over several weeks. Side effects depend on the treatment location but may include skin reactions, delayed wound healing if given preoperatively, and potential effects on nearby structures.

Supportive care during treatment for synovial cell sarcoma addresses pain management, nutritional support, and overall wellbeing. Adequate pain control throughout the treatment process requires ongoing assessment and medication adjustment as needed. Nutritional support ensures adequate caloric intake during a period when stress and treatment may reduce appetite. Post-surgical wound care is important for proper healing. Rehabilitation and physical therapy may help cats adapt to ambulation following amputation, though most cats figure this out naturally. Emotional support for both the cat and family members helps manage the stress of dealing with a serious cancer diagnosis.

Chemotherapy may be considered as part of the treatment protocol for synovial cell sarcoma, though its role is not as well established as for some other tumors. Doxorubicin is the most commonly used chemotherapy agent for soft tissue sarcomas in cats. Chemotherapy may be recommended following surgery to address potential microscopic metastatic disease, particularly for high-grade tumors or those with concerning prognostic features. The decision to include chemotherapy depends on multiple factors including tumor grade, surgical margins, presence of metastasis, and owner preferences. Discussion with a veterinary oncologist helps determine whether chemotherapy is appropriate for an individual patient.

Recovery from synovial cell sarcoma treatment varies depending on whether amputation or limb-sparing surgery was performed. Cats recovering from amputation typically adapt faster than owners anticipate. Most cats begin walking within twenty-four to forty-eight hours of surgery and are moving comfortably within one to two weeks. Initial recovery focuses on incision healing, pain management, and gradual return to activity. Cats who undergo limb-sparing surgery require recovery time for wound healing plus rehabilitation of the affected limb, which may take longer than amputation recovery. Radiation therapy side effects peak one to two weeks after treatment completion and generally resolve over the following weeks.

Post-treatment care requirements following surgery for synovial cell sarcoma require commitment from cat owners. Surgical incisions should be monitored daily for signs of infection, excessive swelling, or wound breakdown. Elizabethan collars prevent cats from licking or chewing at incision sites. Pain medications should be administered as prescribed, and owners should communicate any concerns about inadequate pain control to the veterinary team. Activity restriction during initial healing prevents stress on surgical sites and may require confinement to a small area. Follow-up appointments for wound checks, suture removal, and ongoing assessment are scheduled according to the surgeon's recommendations.

Prognosis for cats with synovial cell sarcoma depends heavily on treatment type and completeness of tumor removal. Cats treated with amputation, which achieves the widest possible margins, generally have better local control than those treated with limb-sparing approaches. Histological grade influences prognosis, with high-grade tumors having more aggressive behavior. Tumor size at diagnosis affects both surgical options and outcomes, with smaller tumors generally having better prognosis. The presence of metastasis at diagnosis significantly worsens the outlook. Given the rarity of feline synovial cell sarcoma, precise survival statistics are limited, but cats with completely excised tumors can achieve extended survival times measured in years.

Long-term outlook following treatment for synovial cell sarcoma requires ongoing monitoring for local recurrence and metastatic disease. Regular veterinary examinations, typically every two to three months initially and then at longer intervals, assess for any evidence of tumor recurrence. Physical examination focuses on the surgery site for cats that had limb-sparing surgery, or the amputation site and remaining limbs. Periodic chest radiographs monitor for lung metastasis. The risk of recurrence is highest in the first one to two years but can occur later. Cats that remain disease-free for extended periods have progressively better long-term outlooks. Owners should monitor at home for any new masses, changes in mobility, or concerning symptoms.

Primary prevention of synovial cell sarcoma in cats is not currently possible because the specific causes of this tumor remain unknown. No environmental factors, lifestyle elements, or dietary components have been linked to synovial cell sarcoma risk. The tumor appears to arise spontaneously through mechanisms that cannot be predicted or prevented. The lack of identified hereditary patterns makes genetic testing or selective breeding decisions irrelevant for this condition. Without understanding why synovial cell sarcoma develops, targeted prevention strategies cannot be developed. Research into the causes of this tumor is limited by its rarity in the feline population.

General health maintenance represents the best available approach to supporting cats' overall wellbeing. Feeding a complete and balanced diet appropriate for the cat's life stage supports general health. Maintaining a healthy body weight reduces stress on joints and supports overall wellbeing, though whether this influences synovial cell sarcoma risk is unknown. Regular exercise appropriate to the cat's age and abilities keeps joints healthy and maintains muscle mass. Minimizing exposure to potential toxins and carcinogens is prudent general advice without specific evidence of cancer prevention effects for this tumor type.

Joint health maintenance, while not proven to prevent synovial cell sarcoma, supports overall musculoskeletal wellbeing. Prompt treatment of joint injuries may reduce chronic inflammation, which has been proposed as a potential contributing factor in some periarticular tumors. Managing arthritis and other joint conditions helps maintain mobility and comfort. Appropriate weight management reduces stress on joints. Providing appropriate environmental enrichment that encourages activity without excessive strain on joints supports long-term musculoskeletal health. None of these measures have been proven to prevent synovial cell sarcoma specifically, but they contribute to overall quality of life.

Regular veterinary examinations provide opportunities for professional assessment and early detection of any abnormalities around joints or elsewhere. Annual or semi-annual wellness visits allow thorough physical examination by trained professionals. Cat owners should monitor their cats' mobility and bring any persistent lameness, joint swelling, or masses near joints to veterinary attention promptly. Older cats, who are at higher risk for various cancers, may benefit from more frequent monitoring. Because no specific screening tests exist for synovial cell sarcoma, vigilant monitoring for clinical signs remains the primary approach to early detection.

Early intervention when suspicious symptoms develop offers the best chance for successful treatment of synovial cell sarcoma. Persistent lameness that does not respond to rest or basic pain management warrants thorough evaluation including radiographs. Any mass or swelling near a joint should be evaluated rather than assumed to be benign. Cat owners should not dismiss lameness as simply aging without proper veterinary assessment. The earlier synovial cell sarcoma is detected and treated, the better the chance for complete excision and long-term control. A collaborative relationship with a veterinarian ensures that concerning symptoms receive appropriate and timely attention.

Daily management of a cat recovering from or living with treated synovial cell sarcoma requires attention to the cat's mobility, comfort, and overall wellbeing. For cats who have undergone amputation, the adaptation process is usually smoother than owners anticipate, but some environmental modifications can help. Providing easy access to essential resources including food, water, and litter boxes minimizes the effort required for daily activities. During the initial recovery period, confining the cat to a single level prevents stair-related accidents while the cat learns to balance on three legs. As the cat becomes more confident, normal access to the home can be gradually restored. Monitoring the cat's gait and mobility helps identify any developing problems.

Creating an appropriate home environment supports long-term quality of life for cats after synovial cell sarcoma treatment. For three-legged cats, providing ramps or steps to favorite resting spots allows access without the jumping that can be more challenging on three legs. Non-slip surfaces in frequently used areas help prevent slipping. Litter boxes with low sides facilitate easy entry and exit. Multiple comfortable resting spots throughout the home allow the cat to choose locations without navigating long distances. Maintaining a stable environment with furniture in predictable locations helps cats navigate efficiently. Most three-legged cats become remarkably adept at moving through their environment over time.

Maintaining quality of life is the central goal in managing cats treated for synovial cell sarcoma. Many cats enjoy excellent quality of life following treatment, particularly amputation, which eliminates the tumor and the associated pain. Three-legged cats can play, climb, hunt toys, and engage in normal cat behaviors, often with remarkable agility. Mental stimulation through interactive toys, window perches, and environmental enrichment supports psychological wellbeing. Comfortable resting areas with soft bedding provide pleasant spots for relaxation. Regular assessment of comfort and function helps identify any problems early so they can be addressed. Focusing on what the cat can do rather than limitations helps maintain positive perspectives for both cats and their families.

Ongoing monitoring and veterinary care continue throughout the cat's life after synovial cell sarcoma treatment. Regular recheck examinations assess for any signs of local recurrence or metastatic disease. For cats who had limb-sparing surgery, careful examination of the surgical site checks for local tumor recurrence. Periodic chest radiographs may be recommended to monitor the lungs. At home, owners should monitor for any new masses, changes in breathing, or alterations in activity level. Weight monitoring helps detect changes that might indicate disease progression. Maintaining a journal of observations can identify subtle trends and provides valuable information for veterinary visits.

Caregiver support helps owners navigate the challenges of caring for a cat with cancer. The emotional impact of a serious diagnosis and treatment decisions can be significant. Veterinary team members can provide education and emotional support throughout the treatment journey. Online communities connect pet owners facing similar challenges, offering opportunities to share experiences. The decision to proceed with amputation, while medically straightforward, can be emotionally difficult for owners, and support during this decision-making process is valuable. Financial stress from treatment costs can compound emotional challenges, and discussing concerns with the veterinary team may identify options for managing expenses. Celebrating the cat's resilience and focusing on quality time together helps maintain perspective throughout the experience.

Synovial cell sarcoma does not show clear breed predisposition in cats, and the tumor occurs across all breeds including domestic shorthairs, domestic longhairs, and various purebred cats. The absence of breed associations suggests that breed-specific genetic factors do not play a major role in susceptibility. Domestic shorthairs and longhairs comprise the majority of synovial cell sarcoma cases because they represent the majority of the cat population, not because they have elevated risk compared to other breeds. The rarity of the tumor limits the statistical power to detect subtle breed associations that might exist. When synovial cell sarcoma occurs in purebred cats, no particular breed stands out as being affected more commonly than others.

Demographic factors associated with synovial cell sarcoma follow patterns typical of many adult-onset cancers. Middle-aged to older cats are more commonly affected than young cats, consistent with the understanding that cancer risk generally increases with age as genetic mutations accumulate. Both male and female cats can develop synovial cell sarcoma, with no consistent sex predisposition reported. The tumor shows predilection for certain joint locations, particularly the stifle, hock, and elbow joints, but this likely reflects anatomical factors rather than demographic ones. Large body size has been associated with synovial sarcoma in dogs, but this relationship has not been established in cats.

Screening recommendations for synovial cell sarcoma apply broadly to all cats rather than targeting specific breeds. Regular veterinary examinations provide opportunities for professional assessment of joint health and detection of any periarticular masses or abnormalities. Cat owners should monitor their cats' mobility and bring any persistent lameness or joint swelling to veterinary attention. Periodic palpation around major joints during home grooming or petting can help detect masses early. Older cats may benefit from more frequent veterinary checkups given their increased risk for various health conditions. Because no specific genetic tests or screening biomarkers exist for synovial cell sarcoma, vigilant monitoring for clinical signs remains the primary approach to early detection.

Other soft tissue sarcomas can occur near joints in cats and must be differentiated from synovial cell sarcoma through histopathological examination. Fibrosarcoma is the most common soft tissue sarcoma in cats and can arise in periarticular locations. Peripheral nerve sheath tumors may occur near joints where nerves pass. Undifferentiated sarcoma and other mesenchymal tumors represent additional differential considerations. Histiocytic sarcoma can arise in joint-associated tissues and may have similar clinical presentation. Accurate identification of the specific tumor type through histopathology and immunohistochemistry is important because biological behavior and prognosis may vary among these tumors. Treatment approaches are generally similar, centering on aggressive surgical excision, but specific prognostic information helps guide owner expectations and decisions.

Joint diseases that may initially mimic synovial cell sarcoma include infectious and immune-mediated conditions. Septic arthritis, or joint infection, can cause joint swelling, lameness, and pain similar to a periarticular tumor. Immune-mediated polyarthritis causes joint inflammation and swelling that may be confused with neoplasia. Chronic osteoarthritis with associated soft tissue thickening may occasionally raise concern for tumor development. Bone tumors arising in periarticular locations, including osteosarcoma, may present similarly to synovial cell sarcoma. Appropriate diagnostic workup including imaging and tissue sampling distinguishes among these conditions, which have very different treatments and outcomes.

Complications associated with synovial cell sarcoma and its treatment include local recurrence, metastatic spread, and treatment-related problems. Local recurrence is a common concern, particularly after limb-sparing surgery with incomplete margins, and may require additional treatment including potential amputation. Metastasis to the lungs or other sites can develop and significantly affects prognosis. Post-amputation complications are uncommon but may include wound healing problems, phantom limb syndrome, or stress on remaining limbs. Limb-sparing surgery complications may include infection, wound breakdown, or functional impairment of the preserved limb. Long-term complications for three-legged cats may include arthritis in remaining joints from altered weight bearing. Regular monitoring facilitates early detection and management of any complications.